Details of the Drug Reposition

General Information of This Drug (ID: DMQGI8R)

Drug Name
CD20 CAR T cells   DMQGI8R
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 2 [1]
B-cell chronic lymphocytic leukaemia DISNHN2M 2A82.00 Phase 2 [1]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02846584) a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies